Posted in | News | Business

BASF Increases Stake in Leading Provider of Technology and Services Company

BASF SE and hte have reached an agreement for BASF to increase its stake in Heidelberg-based hte Aktiengesellschaft from 12.7 percent to 75 percent plus one share. The vendors and BASF have agreed not to disclose financial details of the transaction, which is still subject to merger control clearing.

The high throughput experimentation company, hte, is a leading provider of technology and services for enhancing research and development productivity, in particular in the areas of catalysis, material science and formulations. BASF has held a stake in the company since 2003 through its subsidiary BASF Venture Capital. After the transaction, hte’s operations will be unchanged and hte will continue to serve its international client base.

“BASF will benefit especially from hte’s experience as a global leader in the application of high throughput methods to heterogeneous catalyst R&D,” said Professor Dr. Rainer Diercks, President, Chemicals Research & Engineering at BASF. “As a result, we will be able to develop catalysts for a variety of applications faster and more efficiently.”

“The extension of BASF’s commitment to hte is a clear endorsement of our company’s technology and expertise offering and will afford hte long-term stability and a solid basis for future planning and investing in new technology development,” said Dr. Dirk Demuth, CEO of hte. “Since hte will continue to operate as an independent provider of technology and R&D services, all of our clients will benefit from this transaction,” added Dr. Wolfram Stichert, CFO of hte.

Posted April 3rd,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.